Press Releases

Date Title and Summary
Toggle Summary Accuray Receives AERB Approval for Sale and Supply of its Radixact® X9 System in India
SUNNYVALE, Calif. , June 21, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company has received an Atomic Energy Regulatory Board (AERB) Type Approval for its Radixact ® X9 System in India . The AERB Type Approval indicates the device conforms to established
Toggle Summary New Studies Show the Accuray TomoTherapy® System Provides Greater Precision, Excellent Clinical Outcomes in Patients Undergoing Total Body Irradiation
SUNNYVALE, Calif. , May 30, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that recently published data from two new studies demonstrate the benefits of the TomoTherapy ® System in the delivery of total body irradiation (TBI), a procedure commonly used to prepare patients
Toggle Summary Accuray CyberKnife® Customer Achieves Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan Study
- Results Demonstrate Exceptional Treatment Plan Quality Achievable with Accuray Treatment Planning Software (TPS) - Renowned Clinical Trials Group TROG Cancer Research and ProKnow Partnered to Host Study SUNNYVALE, Calif. , May 22, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY)
Toggle Summary Mercy Advances Cancer Care in Missouri with Multi-System, Multi-Hospital Agreement for Accuray Radiation Therapy Systems
- One-of-a-kind Accuray Radixact® and CyberKnife® Systems Offer Technological Innovations Designed to Deliver Unique Patient Benefits - Mercy is First in Missouri to Acquire the Radixact and CyberKnife M6™ Systems SUNNYVALE, Calif. , May 9, 2018 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY)
Toggle Summary Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
SUNNYVALE, Calif. , May 4, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Patrick Spine , the company's new Senior Vice President, Human Resources.  As a material inducement to Mr.
Toggle Summary Accuray Reports Third Fiscal Quarter Results
SUNNYVALE, Calif. , April 30, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third fiscal quarter ended March 31, 2018 . Fiscal Third Quarter Highlights Revenue increased 3 percent year over year to $99.8 million driven by service revenue growth
Toggle Summary South Florida Radiation Oncology Treats First Cancer Patients Using Its New CyberKnife® M6™ System
Innovative Radiation Therapy Device Enables Cancer Center to Provide Faster, Extremely Precise Radiation Treatments SUNNYVALE, Calif. , April 24, 2018 /PRNewswire/ -- Accuray Incorporated's (NASDAQ: ARAY) CyberKnife ® M6™ System with the InCise™ Multileaf Collimator (MLC) is enabling clinicians at
Toggle Summary Accuray to Bring Patient-First Cancer Treatment Innovations to ESTRO 37
Unique Hologram Technology Will Showcase the Benefits Accuray Radiotherapy Systems and Software Solutions Provide to Patients SUNNYVALE, Calif. , April 17, 2018 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) announced today it will be showcasing the benefits of its radiotherapy systems and
Toggle Summary Accuray To Report Fiscal 2018 Third Quarter Financial Results On April 30, 2018
SUNNYVALE, Calif. , April 9, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2018 on Monday, April 30, 2018 after the market close, following the annual European Society for Radiotherapy and Oncology (ESTRO) meeting taking place
Toggle Summary Apollo Hospitals in India to Acquire Two Accuray Radixact® Systems
New Systems Will Improve the Treatment Process Workflow, Enabling Clinicians to Treat More Patients Every Day SUNNYVALE, Calif. , March 28, 2018 /PRNewswire/ -- Personalized, precise, radiation treatments will soon be available to more cancer patients in India .